1. Home
  2. PSIX vs CRVS Comparison

PSIX vs CRVS Comparison

Compare PSIX & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Power Solutions International Inc.

PSIX

Power Solutions International Inc.

HOLD

Current Price

$32.58

Market Cap

929.2M

Sector

Industrials

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.89

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSIX
CRVS
Founded
1985
2014
Country
United States
United States
Employees
1000
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
929.2M
1.1B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
PSIX
CRVS
Price
$32.58
$14.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$99.95
$30.17
AVG Volume (30 Days)
380.1K
1.4M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.73
N/A
Revenue Next Year
$16.20
N/A
P/E Ratio
$17.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.90
$3.96
52 Week High
$121.47
$26.95

Technical Indicators

Market Signals
Indicator
PSIX
CRVS
Relative Strength Index (RSI) 32.01 57.88
Support Level N/A $14.24
Resistance Level $43.75 $16.85
Average True Range (ATR) 1.99 0.81
MACD -0.02 0.12
Stochastic Oscillator 8.71 60.08

Price Performance

Historical Comparison
PSIX
CRVS

About PSIX Power Solutions International Inc.

Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States, and also has its presence in North America (outside of United States), Pacific Rim, Europe and Others.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: